Viatris outlines vision for growth through 2030

Viatris (VTRS) will host its Investor Event, where members of the executive leadership team will outline the Company’s strategic vision, key drivers and financial framework expected to deliver sustained revenue and earnings growth through 2030. Long-Term Financial Targets and Capital Allocation: For its Combined Long-Term Targets through 2030, the Company expects to deliver 5% to 6% Total Revenues CAGR, 7% to 8% Adjusted EBITDA CAGR, 9% to 10% Adjusted EPS CAGR and more than $3 billion in annual free cash flow in 2030. The Combined Long-Term Targets are comprised of the Company’s Base Case Long-Term Targets and Potential Additional Drivers. For its Base Case Long-Term Targets through 2030, Viatris expects its base business, supported by anticipated upcoming launches of value-added medicines, to deliver 3% to 4% Total Revenues CAGR, 4% to 5% Adjusted EBITDA CAGR, including operating leverage from the cost savings resulting from its Enterprise-Wide Strategic Review, 6% to 7% Adjusted EPS CAGR, including the benefit from future expected share repurchases, and more than $2.7 billion in annual free cash flow in 2030.